 Antibodies
"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Autoantibodies
- Immune Sera
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in this website by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 8 | 8 | | 1996 | 1 | 3 | 4 | | 1997 | 0 | 5 | 5 | | 1998 | 1 | 8 | 9 | | 1999 | 0 | 5 | 5 | | 2000 | 1 | 8 | 9 | | 2001 | 1 | 6 | 7 | | 2002 | 0 | 8 | 8 | | 2003 | 0 | 9 | 9 | | 2004 | 2 | 11 | 13 | | 2005 | 6 | 8 | 14 | | 2006 | 3 | 4 | 7 | | 2007 | 2 | 4 | 6 | | 2008 | 3 | 8 | 11 | | 2009 | 2 | 4 | 6 | | 2010 | 3 | 5 | 8 | | 2011 | 3 | 1 | 4 | | 2012 | 4 | 4 | 8 | | 2013 | 3 | 5 | 8 | | 2014 | 3 | 10 | 13 | | 2015 | 11 | 6 | 17 | | 2016 | 7 | 3 | 10 | | 2017 | 9 | 4 | 13 | | 2018 | 5 | 4 | 9 | | 2019 | 6 | 3 | 9 | | 2020 | 2 | 1 | 3 | | 2021 | 5 | 0 | 5 | | 2022 | 1 | 4 | 5 | | 2023 | 0 | 6 | 6 | | 2024 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies" by people in Profiles.
-
Butler-Dawson J, Johnson RJ, Krisher L, Jaramillo D, Cruz A, Pilloni D, Brindley S, Rodriguez-Iturbe B, Sanchez-Lozada LG, Dally M, Newman LS. A longitudinal assessment of heat exposure and biomarkers of kidney function on heat shock protein 70 and antibodies among agricultural workers. BMC Nephrol. 2024 Aug 28; 25(1):277.
-
Liebhoff AM, Venkataraman T, Morgenlander WR, Na M, Kula T, Waugh K, Morrison C, Rewers M, Longman R, Round J, Elledge S, Ruczinski I, Langmead B, Larman HB. Efficient encoding of large antigenic spaces by epitope prioritization with Dolphyn. Nat Commun. 2024 Feb 21; 15(1):1577.
-
Liu F, Ryan ST, Fahnoe KC, Morgan JG, Cheung AE, Storek MJ, Best A, Chen HA, Locatelli M, Xu S, Schmidt E, Schmidt-Jim?nez LF, Bieber K, Henderson JM, Lian CG, Verschoor A, Ludwig RJ, Benigni A, Remuzzi G, Salant DJ, Kalled SL, Thurman JM, Holers VM, Violette SM, Wawersik S. C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement. Mol Ther. 2024 Apr 03; 32(4):1061-1079.
-
McAteer J, Kalluri DD, Abedon RR, Qin CX, Auerbach SR, Charnaya O, Danziger-Isakov LA, Ebel NH, Feldman AG, Hsu EK, Mohammad S, Perito ER, Thomas AM, Chiang TPY, Garonzik-Wang JM, Segev DL, Werbel WA, Mogul DB. Anti-spike antibody durability after SARS-CoV-2 vaccination in adolescent solid organ transplant recipients. Pediatr Transplant. 2024 Feb; 28(1):e14671.
-
Zhang Y, Patel RP, Kim KH, Cho H, Jo JC, Jeong SH, Oh SY, Choi YS, Kim SH, Lee JH, Angelos M, Guruprasad P, Cohen I, Ugwuanyi O, Lee YG, Pajarillo R, Cho JH, Carturan A, Paruzzo L, Ghilardi G, Wang M, Kim S, Kim SM, Lee HJ, Park JH, Cui L, Lee TB, Hwang IS, Lee YH, Lee YJ, Porazzi P, Liu D, Lee Y, Kim JH, Lee JS, Yoon DH, Chung J, Ruella M. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. Mol Cancer. 2023 12 09; 22(1):200.
-
Anami T, Pan C, Fujiwara Y, Komohara Y, Yano H, Saito Y, Sugimoto M, Wakita D, Motoshima T, Murakami Y, Yatsuda J, Takahashi N, Suzu S, Asano K, Tamada K, Kamba T. Dysfunction of sinus macrophages in tumor-bearing host induces resistance to immunotherapy. Cancer Sci. 2024 Jan; 115(1):59-69.
-
Strobel RJ, Narahari AK, Rotar EP, Young AM, Vergales J, Mehaffey JH, Teman NR, Kern JA, Yarboro LT, Kron IL, Nelson MR, Roeser M. Effect of Cardiopulmonary Bypass on SARS-CoV-2 Vaccination Antibody Levels. J Am Heart Assoc. 2023 09 05; 12(17):e029406.
-
Rhodes ER, Faris JG, Petersen BM, Sprenger KG. Common framework mutations impact antibody interfacial dynamics and flexibility. Front Immunol. 2023; 14:1120582.
-
Kim R, Leal AD, Parikh A, Ryan DP, Wang S, Bahamon B, Gupta N, Moss A, Pye J, Miao H, Inguilizian H, Cleary JM. A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C. Cancer Chemother Pharmacol. 2023 04; 91(4):291-300.
-
Giang J, van Doorn MBA, Diercks GFH, de Cordoba SR, van den Bosch TPP, Schreurs MWJ, Poppelaars F, Damman J. Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid. Exp Dermatol. 2023 05; 32(5):632-640.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|